Congress's Pandemic-Readiness Budget Overrules the President's by $687 Million

Four federal accounts do the work of getting a vaccine or antitoxin from a lab bench into a warehouse and, eventually, an arm: BARDA researches and develops the countermeasure, Project BioShield buys it once it's ready, the Strategic National Stockpile (SNS) stores it, and a separate pandemic-influenza line funds flu-specific readiness.▸ In April 2026, the Administration for Strategic Preparedness and Response's FY2027 budget justification asked Congress to fund those four accounts at $2,625,591,000 combined — $582.4 million below what's currently funded. Six weeks later, the House Appropriations Committee wrote its own number into H. Rept. 119-696: $3,312,991,000. Not a modest correction — $687.4 million above the request, and $105 million above the current baseline.

The steepest cut in the President's budget lands on BARDA, the Biomedical Advanced Research and Development Authority — the office that funded Operation Warp Speed's vaccine contracts.▸ ASPR's own comparably-adjusted budget table shows BARDA falling from $944,349,000 to $654,411,000, a $289.9 million cut — roughly 31%. Project BioShield, which buys finished countermeasures once BARDA-funded research clears the FDA, drops $125 million (14.7%), from $850 million to $725 million. The Strategic National Stockpile itself is nominally flat at $938.189 million, but only because the request folds SNS staff salaries into a newly created "Program Management and Operations" line rather than cutting the stockpile's buying power directly — a bookkeeping move ASPR's justification describes plainly: it "consolidate[s] SNS Federal salaries and expenses into the proposed Program Management and Operation (PMO), maintaining the overall level with FY 2026."

The House Appropriations Committee doesn't have to accept a President's budget request — it's a request, not a mandate — and on the pandemic-readiness accounts, the committee that actually writes the check went the other direction on every one of the four lines.▸ Its June 2026 report funds BARDA at $1,060,000,000 (up $10 million from FY2026, and $405.6 million above the request), the Strategic National Stockpile at the same $1,060,000,000 (up $60 million, and $121.8 million above the request), Project BioShield at $880,000,000 (up $30 million), and Pandemic Influenza Preparedness at $312,991,000 (up $5 million). Every account moved up, not down — from both the current baseline and the President's ask.

The committee's report explains why in its own language, not a press release's. Citing HHS's most recent Medical Countermeasures Preparedness Review — the government's own required annual threat assessment of the stockpile — the report states plainly that the review "found the Department has not met MCM stockpiling requirements for numerous public health threats," and that the SNS "often relies on decades-old products to fulfill other stockpiling requirements."▸ Elsewhere the same report warns that "stockpile levels at the SNS continue to fall dangerously below requirements, particularly for those domestically produced therapeutic countermeasures that address Material Threat Determinations and that lack commercial markets, such as Anthrax antitoxin." Those are the government's own auditors describing gaps in a system the President's budget proposed funding at $582 million less than it currently gets.

One number stayed flat through all of it.▸ The Strategic National Stockpile is run day-to-day by 181 federal positions — 167 civilian, 14 military — according to ASPR's own FY2027 staffing table, and that headcount doesn't change across FY2025, FY2026, or the FY2027 request. The dollar figure attached to "Strategic National Stockpile" on the org chart moves because the request reclassifies where those 181 salaries are booked, not because the positions are cut. ASPR's total workforce ceiling — 950 full-time-equivalent positions — is identically flat across the same three years. Whatever happens to the dollars, the same number of people are still the ones filling out the stockpile's threat reviews, running its warehouses, and writing the reports that tell Congress where the gaps are.

This is a request and a committee recommendation, not enacted law — the House Committee's bill still needs to clear the full House, the Senate, and reconciliation before any of these numbers are final. Figures cover four specific ASPR accounts (BARDA, Project BioShield, SNS, and Pandemic Influenza Preparedness), not ASPR's full budget, which also includes the National Disaster Medical System, Health Care Readiness and Recovery, and other lines not covered here.